Cardlytics (CDLX) Tops Q3 EPS by 66c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of $0.01, $0.66 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $79 million versus the consensus estimate of $80.01 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• L3Harris CEO steps down amid conduct review, shares drop
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30